Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Biochemistry ; 38(37): 11933-41, 1999 Sep 14.
Article in English | MEDLINE | ID: mdl-10508396

ABSTRACT

Mutational studies of regions that make up the oligomeric interface within the RecA protein filament structure have shown that F217 is an important determinant of RecA function and oligomer stability. All substitutions, other than Tyr and Cys, completely inhibit RecA activities and exhibit a substantial decrease in protein filament stability [Skiba, M. C., and Knight, K. L. (1994) J. Biol. Chem. 269, 3823-3828; Logan, K. M., et al. (1997) J. Mol. Biol. 266, 306-316]. Although the RecA crystal structure exhibits no obvious constraints that explain this mutational stringency, the structure does reveal a hydrophobic pocket in the neighboring monomer that may accommodate the F217 side chain. Together with the F217C mutation, we have introduced a series of Cys substitutions within the interacting surface on the neighboring monomer and have tested for disulfide formation under various conditions, e.g., with or without ATP and ssDNA. We show that the location of F217 in the crystal structure is in general agreement with its position in the catalytically active RecA-ATP-DNA complex. Functional studies with the mutant proteins support the idea that ATP-induced movement of the wild-type F217 side chain toward this hydrophobic pocket is important in mediating allosteric changes in the RecA protein structure.


Subject(s)
Cross-Linking Reagents/chemistry , Disulfides/chemistry , Rec A Recombinases/chemistry , Rec A Recombinases/genetics , Bacterial Proteins/genetics , Chromatography, Gel , Cysteine/chemistry , Cysteine/genetics , DNA Repair , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli/growth & development , Models, Molecular , Mutagenesis, Insertional , Protein Engineering , Rec A Recombinases/chemical synthesis , Rec A Recombinases/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Serine Endopeptidases/genetics
2.
J Mol Biol ; 266(2): 306-16, 1997 Feb 21.
Article in English | MEDLINE | ID: mdl-9047365

ABSTRACT

We have analyzed the oligomeric properties of a number of mutant RecA proteins containing single amino acid substitutions within one region of the subunit interface. In contrast to wild-type RecA, which forms a heterogeneous population of different-sized oligomers, we find that many of these mutant proteins exist in a more homogeneous oligomeric form, which approximates to the size of a RecA hexamer. Some of these mutants have a significant level of activity in vivo for recombinational DNA repair and thus represent the first mutant RecA proteins identified which retain activity yet can exist in a discrete oligomeric state as free protein.


Subject(s)
Mutation , Rec A Recombinases/chemistry , Rec A Recombinases/genetics , Arginine/genetics , Asparagine/genetics , Bacteria/chemistry , Chromatography, Liquid/methods , Crystallography, X-Ray , DNA Repair , Lysine/genetics , Models, Molecular , Phenylalanine/genetics , Protein Conformation , Rec A Recombinases/metabolism , Tyrosine/genetics
3.
J Biol Chem ; 269(5): 3823-8, 1994 Feb 04.
Article in English | MEDLINE | ID: mdl-8106426

ABSTRACT

Assembly of RecA subunits into long, helical oligomers is required for its roles in recombinational DNA repair and homologous genetic recombination. The crystal structure of RecA reveals an extensive network of amino acid residues that lie at the subunit boundaries. We have introduced a large set of substitutions at 5 clustered residues, which are shown in the crystal structure to make specific contacts with positions in the neighboring monomer. We find that 3 of the 5 residues are important for RecA function (Lys216, Phe217, and Arg222), whereas the other 2 (Asn213 and Tyr218) are not. The patterns of functionally allowed substitutions provide insight into the chemical and steric constraints required at these positions.


Subject(s)
Escherichia coli/metabolism , Protein Conformation , Rec A Recombinases/chemistry , Amino Acid Sequence , Binding Sites , Crystallography, X-Ray , DNA Repair , Escherichia coli/genetics , Escherichia coli/radiation effects , Genes, Bacterial , Macromolecular Substances , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Plasmids , Protein Structure, Secondary , Rec A Recombinases/biosynthesis , Rec A Recombinases/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombination, Genetic , Ultraviolet Rays
4.
J Neurosci Res ; 27(4): 472-8, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2079710

ABSTRACT

The inherited deficiency of galactosylceramide beta-galactosidase (E.C. 3.2.1.46: galactocerebrosidase) activity results in globoid cell leukodystrophy in humans (Krabbe disease) and in mice (twitcher mutant). To determine whether Krabbe patients' cells complement twitcher cells to produce, in hybrid combination, greater than deficient levels of galactocerebrosidase activity, five separate crosses were made between an established twitcher mouse cell line and five cell strains from unrelated Krabbe disease patients. A total of 57 twitcher mouse/Krabbe somatic cell hybrid lines developed from all of these crosses were deficient in galactocerebrosidase activity despite the presence of human chromosomes 14 or 17, which have been previously implicated as bearing the galactocerebrosidase gene. A control cross between twitcher mouse/positive control human fibroblasts resulted in 14 of 21 independent hybrid lines that expressed higher than deficient levels of galactocerebrosidase activity. The lack of complementation between Krabbe disease patient and twitcher mutant mouse cells provides further evidence that the twitcher mouse is an authentic murine model for Krabbe disease and supports the hypothesis that the mutations in both species are within the structural gene for the galactocerebrosidase enzyme.


Subject(s)
Galactosylceramidase/genetics , Leukodystrophy, Globoid Cell/genetics , Animals , Cell Line , Electrophoresis, Starch Gel , Fibroblasts/metabolism , Galactosylceramidase/deficiency , Humans , Hybrid Cells , Isoenzymes/analysis , Leukodystrophy, Globoid Cell/enzymology , Mice , Mice, Neurologic Mutants
5.
Am J Hum Genet ; 44(2): 198-207, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2912067

ABSTRACT

Somatic cell hybrids derived from twitcher mouse cells and from control human fibroblasts were selected by two different methods. One method utilized 6-thioguanine-resistant twitcher cells as a parental line and the other used neomycin-resistant control human fibroblasts as a parental line so that hybrid lines could be selected in either HAT or in G-418 medium, respectively. The hybrid lines were analyzed for galactocerebrosidase activity. Since the twitcher cell lines are deficient in galactocerebrosidase activity, the presence of this activity in these hybrid lines depends upon the presence of human chromosome contents. Both galactocerebrosidase-positive and -deficient hybrid lines were analyzed for their human chromosome contents by the use of isozyme markers. In hybrids derived from both selection methods the expression of galactocerebrosidase activity was associated with the presence of human chromosome 17 marker isozymes. This was confirmed cytogenetically by means of trypsin-banded Giemsa staining of intact human chromosome 17 in three galactocerebrosidase-positive hybrid lines.


Subject(s)
Chromosomes, Human, Pair 17 , Galactosidases/genetics , Galactosylceramidase/genetics , Genetic Linkage , Leukodystrophy, Globoid Cell/genetics , Animals , Chromosome Mapping , Fibroblasts , Galactosylceramidase/deficiency , Genetic Markers , Humans , Hybrid Cells , Karyotyping , Leukodystrophy, Globoid Cell/enzymology , Mice , Mice, Mutant Strains
6.
In Vitro Cell Dev Biol ; 24(6): 575-80, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3391933

ABSTRACT

Primary cell cultures from twitcher (galactocerebrosidase deficient) mice were made by enzymatic dispersion and explantation of skin obtained from 3-d-old littermates of a twi+/twi X twi+/twi mating. Galactocerebrosidase activity remained deficient for two twitcher cell lines, TM-1 and TM-2, and both lines demonstrated an initial period of growth decline, followed by accelerated growth. The TM-2 line has been subcultured for more than 3.5 yr, has a modal chromosome number of 63, a doubling time of approximately 16 h, and has remained galactocerebrosidase deficient throughout its life span. These data indicate this to be an established twitcher cell line that can be continuously maintained in culture as a transformed galactocerebrosidase-deficient mouse cell line. This established line was rendered 6-thioguanine resistant so that the cells could be fused with control human fibroblasts and selected for hybrid lines in hypoxanthine-aminopterin-thymidine medium. Also, the established twitcher cells were crossed with neomycin-resistant control human fibroblasts and selected in G418 medium. Several of the hybrid lines from both crosses had higher than deficient levels of galactocerebrosidase activity initially, followed by a decrease to twitcher levels during subculture, whereas other lines retained high levels of activity. These results indicate that twitcher-human somatic cell hybrids will express galactocerebrosidase activity and thus may be useful for determining the human chromosome or chromosomes associated with this expression.


Subject(s)
Fibroblasts/enzymology , Galactosidases/deficiency , Galactosylceramidase/deficiency , Hybrid Cells/enzymology , Leukodystrophy, Globoid Cell/enzymology , Aminopterin/pharmacology , Animals , Brain/enzymology , Cell Division , Cell Line , Galactosylceramidase/genetics , Galactosylceramidase/metabolism , Glucosephosphate Dehydrogenase/analysis , Humans , Hypoxanthine , Hypoxanthines/pharmacology , Isoenzymes/analysis , Karyotyping , Kidney/enzymology , Leukodystrophy, Globoid Cell/genetics , Mice , Mice, Inbred C57BL , Mice, Neurologic Mutants , Ouabain/pharmacology , Ploidies , Thymidine/pharmacology , X Chromosome
SELECTION OF CITATIONS
SEARCH DETAIL